( Root (span 1 57)
  ( Nucleus (span 1 48) (rel2par Topic-Shift)
    ( Nucleus (span 1 27) (rel2par span)
      ( Nucleus (span 1 20) (rel2par span)
        ( Nucleus (span 1 14) (rel2par span)
          ( Nucleus (span 1 13) (rel2par span)
            ( Nucleus (span 1 11) (rel2par span)
              ( Nucleus (span 1 9) (rel2par span)
                ( Nucleus (span 1 5) (rel2par span)
                  ( Nucleus (leaf 1) (rel2par span) (text _!Johnson & Johnson reported a 10% rise in third-quarter net income on a 12% sales increase_!) )
                  ( Satellite (span 2 5) (rel2par elaboration-additional-e)
                    ( Nucleus (leaf 2) (rel2par span) (text _!-results_!) )
                    ( Satellite (span 3 5) (rel2par elaboration-object-attribute-e)
                      ( Nucleus (span 3 4) (rel2par Same-Unit)
                        ( Nucleus (leaf 3) (rel2par span) (text _!that were driven particularly by new products_!) )
                        ( Satellite (leaf 4) (rel2par example-e) (text _!including pharmaceuticals_!) )
                      )
                      ( Nucleus (leaf 5) (rel2par Same-Unit) (text _!and the company's professional operations._!) )
                    )
                  )
                )
                ( Satellite (span 6 9) (rel2par elaboration-additional)
                  ( Nucleus (span 6 7) (rel2par span)
                    ( Nucleus (leaf 6) (rel2par span) (text _!Net for the New Brunswick, N.J., maker of health-care products climbed to $265 million, or 80 cents a share, from $240 million, or 71 cents a share, in the year-earlier period._!) )
                    ( Satellite (leaf 7) (rel2par elaboration-additional) (text _!Sales rose to $2.45 billion from $2.2 billion._!) )
                  )
                  ( Satellite (span 8 9) (rel2par elaboration-additional)
                    ( Nucleus (leaf 8) (rel2par span) (text _!The year-ago per-share earnings are adjusted_!) )
                    ( Satellite (leaf 9) (rel2par purpose) (text _!to reflect a 2-for-1 stock split last May._!) )
                  )
                )
              )
              ( Satellite (span 10 11) (rel2par elaboration-additional)
                ( Satellite (leaf 10) (rel2par attribution) (text _!In a statement, Ralph S. Larsen, chairman and chief executive officer, said_!) )
                ( Nucleus (leaf 11) (rel2par span) (text _!the company was pleased with its third-quarter sales performance, "especially in light of the extremely competitive environment in domestic consumer markets and the negative impact of unfavorable exchange rates this quarter."_!) )
              )
            )
            ( Satellite (span 12 13) (rel2par elaboration-additional)
              ( Satellite (leaf 12) (rel2par attribution) (text _!David J. Lothson, an industry analyst for PaineWebber Group Inc., said_!) )
              ( Nucleus (leaf 13) (rel2par span) (text _!Johnson & Johnson's results slightly exceeded his expectations for the third quarter._!) )
            )
          )
          ( Satellite (leaf 14) (rel2par concession) (text _!In New York Stock Exchange composite trading yesterday, Johnson & Johnson shares fell 37.5 cents to $54.625._!) )
        )
        ( Satellite (span 15 20) (rel2par elaboration-additional)
          ( Nucleus (leaf 15) (rel2par List) (text _!Mr. Larsen noted "substantial sales growth" for the recently introduced Acuvue disposable contact lens and Hismanal, a once-a-day antihistamine._!) )
          ( Nucleus (span 16 20) (rel2par List)
            ( Nucleus (span 16 19) (rel2par span)
              ( Nucleus (span 16 18) (rel2par Same-Unit)
                ( Nucleus (leaf 16) (rel2par span) (text _!Eprex,_!) )
                ( Satellite (span 17 18) (rel2par elaboration-additional-e)
                  ( Nucleus (leaf 17) (rel2par span) (text _!used by dialysis patients_!) )
                  ( Satellite (leaf 18) (rel2par elaboration-object-attribute-e) (text _!who are anemic,_!) )
                )
              )
              ( Nucleus (leaf 19) (rel2par Same-Unit) (text _!and Prepulsid, a gastro-intestinal drug, did well overseas,_!) )
            )
            ( Satellite (leaf 20) (rel2par attribution) (text _!he said._!) )
          )
        )
      )
      ( Satellite (span 21 27) (rel2par elaboration-additional)
        ( Nucleus (span 21 26) (rel2par span)
          ( Satellite (span 21 22) (rel2par antithesis)
            ( Nucleus (leaf 21) (rel2par span) (text _!Despite health-care cost controls and programs_!) )
            ( Satellite (leaf 22) (rel2par elaboration-object-attribute-e) (text _!to hold down inventory,_!) )
          )
          ( Nucleus (span 23 26) (rel2par span)
            ( Nucleus (span 23 25) (rel2par Same-Unit)
              ( Nucleus (leaf 23) (rel2par span) (text _!the professional division,_!) )
              ( Satellite (span 24 25) (rel2par elaboration-object-attribute-e)
                ( Nucleus (leaf 24) (rel2par span) (text _!which makes products_!) )
                ( Satellite (leaf 25) (rel2par example-e) (text _!including sutures and surgical stapling equipment,_!) )
              )
            )
            ( Nucleus (leaf 26) (rel2par Same-Unit) (text _!"achieved solid growth,"_!) )
          )
        )
        ( Satellite (leaf 27) (rel2par attribution) (text _!Johnson & Johnson said._!) )
      )
    )
    ( Satellite (span 28 48) (rel2par elaboration-additional)
      ( Nucleus (span 28 29) (rel2par Contrast)
        ( Nucleus (leaf 28) (rel2par span) (text _!But domestic consumer sales slipped 1.2% for the quarter, to $490 million from $496 million._!) )
        ( Satellite (leaf 29) (rel2par explanation-argumentative) (text _!The company cited softness in the retail health and beauty aids category, "as well as the intense competition in the company's sanitary protection product line."_!) )
      )
      ( Nucleus (span 30 48) (rel2par Contrast)
        ( Nucleus (span 30 33) (rel2par span)
          ( Nucleus (span 30 32) (rel2par span)
            ( Nucleus (leaf 30) (rel2par span) (text _!Overseas sales were stronger,_!) )
            ( Satellite (span 31 32) (rel2par explanation-argumentative)
              ( Nucleus (leaf 31) (rel2par span) (text _!principally because of a rebound in Brazil,_!) )
              ( Satellite (leaf 32) (rel2par elaboration-additional-e) (text _!where economic turmoil had hurt year-earlier results,_!) )
            )
          )
          ( Satellite (leaf 33) (rel2par attribution) (text _!Johnson & Johnson said._!) )
        )
        ( Satellite (span 34 48) (rel2par elaboration-additional)
          ( Nucleus (span 34 42) (rel2par span)
            ( Nucleus (span 34 38) (rel2par span)
              ( Satellite (leaf 34) (rel2par attribution) (text _!Mr. Lothson of PaineWebber said_!) )
              ( Nucleus (span 35 38) (rel2par span)
                ( Nucleus (span 35 36) (rel2par span)
                  ( Nucleus (leaf 35) (rel2par span) (text _!the company's sales pace has been picking up_!) )
                  ( Satellite (leaf 36) (rel2par explanation-argumentative) (text _!largely because the effect of unfavorable exchange rates has been easing_!) )
                )
                ( Satellite (span 37 38) (rel2par elaboration-object-attribute-e)
                  ( Nucleus (leaf 37) (rel2par span) (text _!-- a pattern_!) )
                  ( Satellite (leaf 38) (rel2par elaboration-object-attribute-e) (text _!continuing this quarter._!) )
                )
              )
            )
            ( Satellite (span 39 42) (rel2par hypothetical)
              ( Nucleus (span 39 40) (rel2par span)
                ( Satellite (leaf 39) (rel2par attribution) (text _!He cautioned, however,_!) )
                ( Nucleus (leaf 40) (rel2par span) (text _!that a "tough tax-rate comparison" may slow the company's earnings growth for the current quarter._!) )
              )
              ( Satellite (span 41 42) (rel2par elaboration-additional)
                ( Nucleus (leaf 41) (rel2par span) (text _!For last year's fourth quarter, the company's tax rate was less than 20%,_!) )
                ( Satellite (leaf 42) (rel2par attribution) (text _!he said._!) )
              )
            )
          )
          ( Satellite (span 43 48) (rel2par elaboration-additional)
            ( Nucleus (span 43 46) (rel2par span)
              ( Satellite (span 43 44) (rel2par antithesis)
                ( Nucleus (leaf 43) (rel2par span) (text _!While the third period contained no major surprises,_!) )
                ( Satellite (leaf 44) (rel2par attribution) (text _!Mr. Lothson said,_!) )
              )
              ( Nucleus (span 45 46) (rel2par span)
                ( Satellite (leaf 45) (rel2par attribution) (text _!the results show_!) )
                ( Nucleus (leaf 46) (rel2par span) (text _!how sensitive the multinationals can be to developments in a single country such as Brazil._!) )
              )
            )
            ( Satellite (span 47 48) (rel2par elaboration-additional)
              ( Satellite (leaf 47) (rel2par attribution) (text _!He also questioned_!) )
              ( Nucleus (leaf 48) (rel2par span) (text _!whether recent gains in that country can be sustained._!) )
            )
          )
        )
      )
    )
  )
  ( Nucleus (span 49 57) (rel2par Topic-Shift)
    ( Nucleus (leaf 49) (rel2par span) (text _!The following issues were recently filed with the Securities and Exchange Commission:_!) )
    ( Satellite (span 50 57) (rel2par elaboration-set-member)
      ( Nucleus (leaf 50) (rel2par List) (text _!Bergen Brunswig Corp., proposed offering of liquid yield option notes, via Merrill Lynch Capital Markets._!) )
      ( Nucleus (leaf 51) (rel2par List) (text _!Columbia Gas System Inc., shelf offering of up to $200 million of debentures._!) )
      ( Nucleus (span 52 53) (rel2par List)
        ( Nucleus (leaf 52) (rel2par span) (text _!Laserscope, initial offering of 1,656,870 common shares,_!) )
        ( Satellite (leaf 53) (rel2par elaboration-additional-e) (text _!of which 1,455,000 shares are to be sold by the company and 201,870 by holders, via Alex. Brown & Sons Inc. and Volpe, Covington & Welty._!) )
      )
      ( Nucleus (span 54 55) (rel2par List)
        ( Nucleus (leaf 54) (rel2par span) (text _!TeleVideo Systems Inc., proposed offering of 1,853,735 common shares,_!) )
        ( Satellite (leaf 55) (rel2par elaboration-object-attribute-e) (text _!to be sold by holders._!) )
      )
      ( Nucleus (span 56 57) (rel2par List)
        ( Nucleus (leaf 56) (rel2par span) (text _!Western Gas System Inc., initial offering of 3,250,000 common shares,_!) )
        ( Satellite (leaf 57) (rel2par elaboration-additional-e) (text _!of which 3,040,000 shares will be sold by the company and 210,000 by a holder, via Prudential-Bache Capital Funding, Smith Barney, Harris Upham & Co. and Hanifen, Imhoff Inc._!) )
      )
    )
  )
)
